Scientist I, CSI Development and Implementation Strategy

BlueRock Therapeutics

Toronto, Ontario Onsite Gmp Manufacturing Full-time

About this role

Who is BlueRock?

BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.

What Are We Doing?

Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.

We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.

As part of BlueRock Therapeutics’ vision to change the future of medicine by enabling ground-breaking cell therapies, the candidate will be a technical contributor of a dynamic and innovative team developing formulations for cellular medicines.

The successful candidate will support the development of CSI (cell suspension for injection) formulation at BlueRock by identifying, designing, and testing formulations to optimize in-use stability, cell dose delivery, and cell persistence after transplantation. The ideal candidate will be a highly motivated individual who has demonstrated strong bench skills, excellent documentation skills, attention to detail and enjoys working in a highly cross-functional environment.

As a central development resource at the company, the CSI Development team works closely with other product development teams to understand requirements and develop cellular formulations for applications in therapeutic areas such as cardiology, neurology and immunology. Collaboration with a highly motivated, world-class team of scientists and engineers promises an exciting and engaging work environment for motivated, self-starting candidates.